Results 61 to 70 of about 178,848,266 (217)
The Role Of Hmgb1-Related Inflammation Signals In Bronj
Aim or purpose: BRONJ causes prolonged inflammation, resulting in delayed wound healing. High mobility group box-1 (HMGB1) is secreted into the extracellular milieu in response to stimuli, which mediates various inflammatory diseases and affects wound ...
Li Shurong, Yan Jiayi
doaj +1 more source
Bisphosphonates and Their Influence on the Implant Failure: A Systematic Review
Objective: The goal of this systematic review was to study the relationship between the use of bisphosphonates (oral or intravenous) and its effect on implant osseointegration. Methods: The focused question was “In patients medicated with bisphosphonates
Cristiana Gomes Rebelo +4 more
doaj +1 more source
The scoping review summarizes the current preclinical and clinical evidence for the use of “cell‐free” therapies in craniofacial (periodontal, bone and soft‐tissue) regeneration. It also aims to highlight key challenges and strategies towards the clinical translation of these therapies.
Siddharth Shanbhag +6 more
wiley +1 more source
Medication-Related Osteonecrosis of Jaw
Medication-related osteonecrosis of the jaws (MRONJ) primarily occurs as a complication of bone antiresorptive treatment in specific bone treatment modalities. It was first identified in 2003 as a bisphosphonate (BP) treatment complication. Denosumab is a molecule with a particular mode of action.
Yue He +4 more
openaire +2 more sources
This systematic review and meta-analysis aims at assessing the effect of drug holiday (discontinuation) in preventing the development of medication-related osteonecrosis of the jaw (MRONJ) in patients receiving antiresorptive medications and are in need ...
Duaa Salem Almohammadi +5 more
core +1 more source
Background and Objectives: In this experimental study, the prophylactic effect of systemically administered erythropoietin (EPO) in medication-related osteonecrosis of the jaw (MRONJ) was evaluated.
Gonca Duygu +4 more
doaj +1 more source
Fibrous Dysplasia and Medication-Related Osteonecrosis of the Jaw [PDF]
Osteonecrosis of the jaw (ONJ) is an established side effect of intravenous bisphosphonates and other antiresorptive medications. Although bisphosphonates are frequently prescribed for patients with the skeletal disorder fibrous dysplasia (FD), there are no reports of ONJ in this population.
Tarek, Metwally +4 more
openaire +2 more sources
Cell Therapy for Periodontal, Soft‐Tissue, and Craniofacial Regeneration
The clinical translation of mesenchymal stem/stromal cells (MSCs) represents a major advancement in dentistry, especially for periodontal, soft‐tissue, and craniofacial regeneration. However, several challenges remain to be addressed, including the absence of standardised protocols, limited scalability, regulatory hurdles, a lack of well‐controlled ...
Kamal Mustafa +5 more
wiley +1 more source
Bone Grafts: Everything You Need to Know
This review classifies bone grafts (autograft, allograft, xenograft, synthetic) by source and osteogenic/inductive/conductive potential, linking material properties and mechanisms to clinical indications in periodontal and dental regeneration. Key challenges—limited osteoinduction, poor vascularisation, unbalanced resorption, handling difficulties, and
Håvard Jostein Haugen +5 more
wiley +1 more source
Treatment of Medication-Related Osteonecrosis of the Jaw
Medication-related osteonecrosis of the jaw (MRONJ) is a most interesting, complex and elusive condition seen by the oral health care provider. It is plagued by controversy and although a wealth of research has created clinical treatment databases ...
Adams, David Russell +3 more
core +1 more source

